93246-54-9

Basic information

• Product Name: AKOS B033532
• Synonyms: TIMTEC-BB SBB010658;AKOS B033532;3-FLUORO-4-(1-PYRROLIDINYL)ANILINE;3-FLUORO-4-(PYRROLIDIN-1-YL)ANILINE;3-FLUORO-4-PYRROLIDIN-1-YL-PHENYLAMINE
• CAS NO: 93246-54-9
• Molecular Formula: C₁₀H₁₃FN₂
• Molecular Weight: 180.225
• Mol File: 93246-54-9.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: AKOS B033532(CAS DataBase Reference)
• NIST Chemistry Reference: AKOS B033532(93246-54-9)
• EPA Substance Registry System: AKOS B033532(93246-54-9)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 93246-54-9(Hazardous Substances Data)

Usage

General Description

AKOS B033532 is a chemical compound that is also known as 6-methyl-2,3,4,9-tetrahydro-1H-carbazole. It is a heterocyclic compound with a molecular formula C13H13N and a molecular weight of 183.25 g/mol. AKOS B033532 is a yellow crystalline solid that is used in the synthesis of pharmaceuticals and organic compounds. It is a key intermediate in the production of various drugs and has potential applications in the field of medicinal chemistry. Additionally, AKOS B033532 may also have uses in research and development of new pharmaceuticals and materials.

Upstream product

• 369-34-6 3,4-difluoronitrobenzene 
• 385380-74-5 3-fluoro-1-nitro-4-pyrrolidinobenzene 

Downstream Products

• 1542258-15-0 3-(3-fluoro-4-(pyrrolidin-1-yl)phenyl)-2,6-dimethylpyrimidine-4(3H)-one 
• 221202-56-8 (S)-N'-benzoyl-N-[[3-[3-fluoro-4-(1-pyrrolidinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]thiourea 
• 221200-70-0 Methanesulfonic acid (R)-3-(3-fluoro-4-pyrrolidin-1-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl ester 
• 221200-93-7 (R)-5-Azidomethyl-3-(3-fluoro-4-pyrrolidin-1-yl-phenyl)-oxazolidin-2-one 
• 221201-27-0 (5S)-5-(aminomethyl)-3-(3-fluoro-4-pyrrolidin-1-ylphenyl)-1,3-oxazolidin-2-one 
• 221200-31-3 (R)-3-(3-Fluoro-4-pyrrolidin-1-yl-phenyl)-5-hydroxymethyl-oxazolidin-2-one 

Relevant articles and documents

NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS

The invention relates to the field of medicine, discloses new nitrogen heterocyclic derivatives, preparation method thereof and as medicament in particular as the treatment and prevention of treating tissue fibrosis of the medicament. The invention also discloses a pharmaceutically acceptable compound of the present invention comprise a pharmaceutical composition and methods for using the composition for the treatment of the human or animal tissue fibrosis of diseases, in particular for treating the human or animal renal interstitial fibrosis, glomerular sclerosis, hepatic fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, skin fibrosis, after the operation of adhering, benign prostate hypertrophy, bone-myocardial, scleroderma, multiple sclerosis, pancreas fibrosis, liver cirrhosis, myosarcoma, neurofibromatosis, interstitial pulmonary fibrosis, diabetic nephropathy, Alzheimer's disease or vascular fibrosis disease in use. (by machine translation)

NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS

The present invention relates to the field of medicine, provided herein are novel nitrogenous heterocyclic compounds, their preparation methods and their uses as drugs, especially for treatment and prevention of tissue fibrosis. Also provided herein are pharmaceutically acceptable compositions comprising the nitrogenous heterocyclic compounds and the uses of the compositions in the treatment of human or animal tissue fibrosis, especially for human or animal renal interstitial fibrosis, glomerular sclerosis, liver fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, postsurgical adhesion, benign prostatic hyperplasia, skeletal muscle fibrosis, scleroderma, multiple sclerosis, pancreatic fibrosis, cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, diabetic nephropathy, alzheimer disease or vascular fibrosis.

N-(3,4-disubstituted phenyl) salicylamide derivatives

A compound represented by the following formula (I) or a salt thereof: wherein R1, R2, R3 and R4 represent hydrogen atom, a halogen atom, cyano group, nitro group, a C1-4 alkyl group, a halogenated C